Eva Herrmann focuses on Internal medicine, Hepatitis C virus, Ribavirin, Radiology and Immunology. Her Internal medicine study frequently draws connections to other fields, such as Gastroenterology. Virology and Virus are the main areas of her Hepatitis C virus studies.
Her Ribavirin research is multidisciplinary, incorporating elements of Hepatitis C, Drug resistance and Hepacivirus. Her Immunology research is multidisciplinary, relying on both Biomarker and COPD. Her Transient elastography research is multidisciplinary, relying on both Hepatic fibrosis and Receiver operating characteristic.
Eva Herrmann mainly focuses on Internal medicine, Gastroenterology, Virology, Immunology and Hepatitis C virus. Her work in the fields of Internal medicine, such as Cirrhosis, overlaps with other areas such as In patient. Her study in Cirrhosis is interdisciplinary in nature, drawing from both Fibrosis and Radiology.
Her studies deal with areas such as Liver transplantation and Pathology as well as Gastroenterology. Her Hepatitis C virus research is multidisciplinary, incorporating perspectives in Interferon and Hepatitis C. Her biological study spans a wide range of topics, including Alpha interferon and Combination therapy.
Her main research concerns Internal medicine, Gastroenterology, Cardiology, Meta-analysis and Retrospective cohort study. Clinical endpoint, Hepatitis C, Adverse effect, Confidence interval and Liver transplantation are among the areas of Internal medicine where she concentrates her study. Her work carried out in the field of Hepatitis C brings together such families of science as Hepatitis B and Hepatitis C virus.
Hepatitis C virus is a subfield of Virus that Eva Herrmann tackles. Her Gastroenterology research incorporates themes from Asthma and Reproducibility. Eva Herrmann combines subjects such as Radiology, Hepatocellular carcinoma, Complication and General surgery with her study of Retrospective cohort study.
The scientist’s investigation covers issues in Internal medicine, Meta-analysis, Gastroenterology, Surgery and In patient. The Internal medicine study combines topics in areas such as Oncology and Cardiology. Her work on Steatosis and Liver disease as part of general Gastroenterology study is frequently linked to Grass pollen allergy, therefore connecting diverse disciplines of science.
The Transient elastography study which covers Short bowel syndrome that intersects with Cirrhosis. The concepts of her Hepatitis C study are interwoven with issues in Virus and Hepatitis B. Her study looks at the intersection of Hepatitis B and topics like Liver biopsy with Receiver operating characteristic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis
Mireen Friedrich-Rust;Mei-Fang Ong;Swantje Martens;Christoph Sarrazin.
Gastroenterology (2008)
Liver Fibrosis in Viral Hepatitis: Noninvasive Assessment with Acoustic Radiation Force Impulse Imaging versus Transient Elastography
Mireen Friedrich-Rust;Katrin Wunder;Susanne Kriener;Fariba Sotoudeh.
Radiology (2009)
Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients.
Christian Friedrich Weber;Klaus Görlinger;Dirk Meininger;Eva Herrmann.
Anesthesiology (2012)
Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C
Michael von Wagner;Miriam Huber;Thomas Berg;Holger Hinrichsen.
Gastroenterology (2005)
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis.
M. Friedrich-Rust;J. Nierhoff;M. Lupsor;I. Sporea.
Journal of Viral Hepatitis (2012)
Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis.
Mireen Friedrich-Rust;Mei-Fang Ong;Eva Herrmann;Volker Dries.
American Journal of Roentgenology (2007)
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
Simone Susser;Christoph Welsch;Christoph Welsch;Yalan Wang;Markus Zettler.
Hepatology (2009)
Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy
Thomas Berg;Christoph Sarrazin;Eva Herrmann;Holger Hinrichsen.
Hepatology (2003)
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.
Anuoluwapo Osinusi;Eric G. Meissner;Yu Jin Lee;Dimitra Bon.
JAMA (2013)
Real-time elastography for the differentiation of benign and malignant thyroid nodules: a meta-analysis.
Jörg Bojunga;Eva Herrmann;Gesine Meyer;Sonja Weber.
Thyroid (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Goethe University Frankfurt
Goethe University Frankfurt
Goethe University Frankfurt
Max Planck Institute for Informatics
University of Bonn
National Institutes of Health
Université Paris Cité
Goethe University Frankfurt
Duke University
National Institute of Allergy and Infectious Diseases
University of Calabria
TU Dortmund University
Emory University
University of Arizona
Xi'an Jiaotong University
Johannes Gutenberg University of Mainz
Wellcome Sanger Institute
Centro Internacional de Agricultura Tropical
Bangor University
Bahauddin Zakariya University
Inland Norway University of Applied Sciences
University of Adelaide
University of Rome Tor Vergata
University of California, San Diego
Johns Hopkins University School of Medicine
Karolinska Institute